Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
918.52
-2.97 (-0.32%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
98
99
Next >
Eli Lilly and Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
June 12, 2024
Via
Benzinga
4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024
June 12, 2024
Consider making moves in these securities, each of which has news that is impacting their share price either positively or negatively.
Via
InvestorPlace
Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
June 12, 2024
Could GLP-1 drugs for weight loss in pets be the next big thing? Success of Novo Nordisk and Eli Lilly in human market could pave the way.
Via
Benzinga
3 Stocks Quietly Preparing for a 10X Surge: June Edition
June 12, 2024
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.
Via
InvestorPlace
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
June 12, 2024
The integration of AI and healthcare is well underway.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
June 10, 2024
Via
Benzinga
7 Trending Stocks With Momentum on Their Side
June 12, 2024
Trending stocks offer an opportunity to ride momentum higher and create quick returns for daring investors.
Via
InvestorPlace
3 Must-Buy Stocks Before the Third Quarter
June 12, 2024
Pounce on these three must buy-stocks before the third quarter starts, and take home solid gains as they soar on an improved economy.
Via
InvestorPlace
Is Eli Lilly the Best Pharmaceutical Stock for You?
June 12, 2024
Eli Lilly is serving a market that may reach $100 billion.
Via
The Motley Fool
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
June 11, 2024
Jim Cramer has expressed his confidence in Eli Lilly and Co, citing the company's diverse drug portfolio and the recent endorsement of its Alzheimer's treatment by FDA advisors.
Via
Benzinga
Exposures
Product Safety
Eli Lilly Has Likely Blockbuster Drug, Elevated To Stock Spotlight: Joins These Names Just Added To IBD's Top Screens
June 11, 2024
Eli Lilly hit another all-time high Tuesday. It's seeing gains in large part because it's a leader in drugs to treat obesity and diabetes
Via
Investor's Business Daily
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Why Are Stocks Down Today?
June 11, 2024
Stocks are down today and investors seeking out the answers to why that's the case will want to stick around for our Tuesday coverage.
Via
InvestorPlace
Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug
June 11, 2024
Eli Lilly stock is up on Tuesday as investors in LLY celebrate an FDA panel putting its support behind the company's Alzheimer's drug.
Via
InvestorPlace
Exposures
Product Safety
Top 4 Health Care Stocks That May Keep You Up At Night This Month
June 11, 2024
Via
Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Shares of Eli Lilly surged as an FDA advisory committee endorsed donanemab, an Alzheimer's treatment shown to significantly impact early-stage patients. The drug's benefits outstripped risks, setting...
Via
Benzinga
Exposures
Product Safety
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
June 11, 2024
The world's biggest healthcare company might become even larger.
Via
The Motley Fool
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
June 11, 2024
Analysts who follow the start-up drugmaker think its stock has a chance to soar, but that doesn't mean it's right for you.
Via
The Motley Fool
Apple, Meta, Celsius, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 10, 2024
On Monday, major U.S. indices closed positively, with the Dow Jones Industrial Average rising by 0.2% to 38,868.04.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Over-Hyped Stocks to Sell Before They Plunge: June Edition
June 10, 2024
Although these popular names may be hot now, soon the market could agree that they are over-estimated stocks to sell.
Via
InvestorPlace
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
The FDA isn't bound by the committee's recommendation, but often follows it.
Via
Investor's Business Daily
Exposures
Product Safety
What's Happening With Eli Lilly Shares On Monday?
June 10, 2024
Eli Lilly reports detailed results from the SYNERGY-NASH phase 2 study. The trial, involving 190 patients with and without type 2 diabetes, showed tirzepatide met the primary endpoint, achieving MASH...
Via
Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
June 10, 2024
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.
Via
Investor's Business Daily
Exposures
Product Safety
7 Blue-Chip Stocks to Add to Your June Buy List
June 10, 2024
There are huge advantages to having blue-chip stocks in your portfolio, particularly when the stock market is on a roll. Consider these.
Via
InvestorPlace
The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?
June 08, 2024
One of the most lucrative sports sponsorship opportunities is jersey patches, and one leading pharmaceutical company may have just struck gold.
Via
The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
June 08, 2024
You can use the wisdom of crowds and their fear and greed motives to profit from these three stocks to buy with plenty of room to run.
Via
InvestorPlace
SPDR ETF Report For Friday, June 7
June 08, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, June 7.
Via
Talk Markets
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
98
99
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.